(19)
(11) EP 1 644 742 A2

(12)

(88) Date of publication A3:
13.01.2005

(43) Date of publication:
12.04.2006 Bulletin 2006/15

(21) Application number: 04717052.7

(22) Date of filing: 04.03.2004
(51) International Patent Classification (IPC): 
G01N 33/74(1980.01)
A61K 48/00(1990.01)
A61P 1/00(2000.01)
A61P 7/00(2000.01)
A61P 11/00(2000.01)
A61K 38/17(1995.01)
A61P 9/00(2000.01)
A61P 29/00(2000.01)
A61P 25/00(2000.01)
A61P 13/00(2000.01)
(86) International application number:
PCT/EP2004/002174
(87) International publication number:
WO 2004/082567 (30.09.2004 Gazette 2004/40)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 17.03.2003 EP 03005470

(71) Applicant: Bayer HealthCare AG
51368 Leverkusen (DE)

(72) Inventors:
  • GOLZ, Stefan
    45326 Essen (DE)
  • BRÜGGEMEIER, Ulf
    42799 Leichlingen (DE)
  • SUMMER, Holger
    42113 Wuppertal (DE)

   


(54) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH DOPAMINE RECEPTOR D1A (DRD1)